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Abstract
It has been hypothesised that substance P (SP) may be produced by primary fibroblastic tendon cells (tenocytes), and that
this production, together with the widespread distribution of the neurokinin-1 receptor (NK-1 R) in tendon tissue, could play
an important role in the development of tendinopathy, a condition of chronic tendon pain and thickening. The aim of this
study was to examine the possibility of endogenous SP production and the expression of NK-1 R by human tenocytes.
Because tendinopathy is related to overload, and because the predominant tissue pathology (tendinosis) underlying early
tendinopathy is characterized by tenocyte hypercellularity, the production of SP in response to loading/strain and the
effects of exogenously administered SP on tenocyte proliferation were also studied. A cell culture model of primary human
tendon cells was used. The vast majority of tendon cells were immunopositive for the tenocyte/fibroblast markers
tenomodulin and vimentin, and immunocytochemical counterstaining revealed that positive immunoreactions for SP and
NK-1 R were seen in a majority of these cells. Gene expression analyses showed that mechanical loading (strain) of tendon
cell cultures using the FlexCell technique significantly increased the mRNA levels of SP, whereas the expression of NK-1 R
mRNA decreased in loaded as compared to unloaded tendon cells. Reduced NK-1 R protein was also observed, using
Western blot, after exogenously administered SP at a concentration of 10
27 M. SP exposure furthermore resulted in
increased cell metabolism, increased cell viability, and increased cell proliferation, all of which were found to be specifically
mediated via the NK-1 R; this in turn involving a common mitogenic cell signalling pathway, namely phosphorylation of
ERK1/2. This study indicates that SP, produced by tenocytes in response to mechanical loading, may regulate proliferation
through an autocrine loop involving the NK-1 R.
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Introduction
Despite recent scientific advances, the mechanisms of chronic
tendon pain and thickening, tendinopathy, are yet not fully
understood. It is now widely accepted that the underlying tissue
changes of tendinopathy, commonly thought to be induced by
mechanical overload, constitute a non-inflammatory pathology
(tendinosis) characterized by hypercellularity and capillary prolifer-
ation [1], but the pathogenesis remains unclear.
In the last decade, evidence in favour of a new theory of
tendinosis pathophysiology has been presented; this hypothesis
suggests that signal substances traditionally thought to be confined
to neurons are produced by the tendon tissue itself and are
involved in the development of tendinosis [2,3]. The neurochem-
ical mediators produced by primary fibroblastic tendon cells
(tenocytes) in human tendinosis tendons in vivo include acetylcholine
[4,5,6], catecholamines [7,8,9], glutamate [10], and the neuro-
peptide substance P (SP) [11]. SP, primarily known for its
involvement in afferent pain mechanisms, also has efferent effects
which may play a role in tendon pathology, such as stimulation of
angiogenesis [12]. It has furthermore been found that exogenously
administered SP promotes cellular proliferation in tendon wound
healing in rats [13,14]. The immunoreactivity for nerve-related SP
is increased in a rat model of Achilles tendon overuse [15], and
human Achilles tendinosis is associated with sprouting of SP
positive nerve fibres [16].
In our recent studies of human Achilles tendon tissue, we
showed that tenocytes express the mRNA for SP (TAC1) [11], and
that the preferred SP receptor (neurokinin-1 receptor [NK-1 R]) is
widely distributed in human tendons (including on the tenocytes
themselves), with more marked expression in tendinosis tissue
[11,17]. NK-1 R belongs to the tachykinin receptor sub-family of
G-protein coupled receptors (GPCRs) [18], and it is well
established that GPCRs are involved in transducing extracellular
signals leading to proliferation [19]. One such well-known
pathway following GPCR stimulation is the activation of
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extracellular-signal-regulated kinases 1 and 2 (ERK1/2).
Mechanical strain is considered to be an important component
in tendon cell activation [22]. However, the possible connection
between strain and production of biochemical mediators, such as
SP, remains unclear. Nevertheless, it is well known that after
prolonged exercise tendons change their biological and biochem-
ical characteristics [22]. For chondrocytes it has been shown that
mechanical strain in vitro generates an intracellular signalling
leading to secretion of SP [23]. Since tendon cells can detect and
communicate mechanical signals to the neighbouring cells by the
exchange of molecules [23] the understanding of adaptation
following strain is probably important in solving the puzzle of
tendinosis.
In view of the above, we hypothesise that SP, possibly produced
by tenocytes in response to mechanical strain, has a role in
tendinosis development, particularly with regard to the induction
and/or exacerbation of excessive or uncontrolled tenocyte
proliferation, a prominent feature of tendinosis pathology [1].
For this hypothesis to be tested, it is imperative to disclose
1.) whether the SP protein is produced by human tenocytes,
2.) whether the SP production is increased in response to
mechanical loading (i.e. strain), 3.) whether SP induces prolifer-
ation of human tenocytes, and if so 4.) if this is a specific effect
mediated through the NK-1 R, and 5.) if there is evidence of
involvement of a common mitogenic cell signalling pathway
(activation of MAPKs).
To study these hypothesised effects of SP, good model systems
are required. We have recently, in an animal model (rabbit) of
Achilles tendinosis [24,25], experimentally demonstrated that the
intratendinous production of SP in vivo indeed increases with
mechanical loading and that this elevation precedes the tendinosis
tissue changes, including hypercellularity [26]. We furthermore
showed that exogenously administered SP accelerates tenocyte
proliferation, as well as angiogenesis, in the rabbit Achilles tendon
during development of tendinosis [27]. Nevertheless, whether
these findings may be generalized to human tendon remains
unknown; moreover, animal models can pose ethical problems in
addition to producing results not directly transferable to human
conditions. Therefore, in this study we established a human
tendon cell culture model to study the expression of SP and the SP
receptor NK-1 R, the endogenous production of SP, with and
without mechanical loading, and the effect on the tendon cells in
vitro by exogenously administered SP, and the mechanistic aspects
of such effects.
Methods
Ethics statement
The studies were approved by the Regional Ethical Review
Board in Umea ˚ and were performed according to the principles of
the Declaration of Helsinki. Written informed consent was
received from all participants.
Primary culture of human Achilles tendon cells
Samples of human Achilles tendons were obtained from the
midportion Achilles tendon of healthy donors, defined as
voluntary individuals having no history of Achilles tendon pain
and demonstrating no structural changes on Colour Doppler
ultrasound examination. The donors were all sports active on a
recreational level. The ventral side of the tendon was exposed 3–
4 cm from its calcaneal insertion through a small lateral skin
incision, and the biopsy was taken with a sterile razor blade (Fig. 1).
There were no complications as a result of the biopsy procedure.
Samples were washed with sterile Hanks’ Balanced Salt Solution
(HBSS; Invitrogen; 14170) and carefully dissected and minced
using a sterile razor blade before they were enzymatically digested
at 37uC, using collagenase (Clostridopeptidase A, C-0130 Sigma)
diluted in D-MEM (Invitrogen; 11960) to obtain a concentration
of 2 mg/ml. The digestion product was then centrifuged at 800 g
for 5 min, the supernatant was discarded, and the pellet was re-
suspended and cultured in D-MEM supplemented with 10% fetal
bovine serum (FBS; Invitrogen; 16000), 1% pen-strep (Invitrogen;
15140) and 0.2% L-Glutamine (Invitrogen; 25030) at 37uCi na
humidified atmosphere of 5% CO2 in air. The medium was
changed every third day until confluence when cells were
harvested using trypsin 0.05% with EDTA (Invitrogen; 25300),
re-suspended in medium and seeded at a 1:3 ratio. Only cells from
the third to sixth passage were used for experiments. Experiments
were carried out in 1% FBS, if not otherwise stated, to limit the
influence and unwanted effects of the serum. The serum-
reduced/-starved cells still appeared healthy macroscopically,
and the growing rate remained in a pattern of steady increase of
the metabolic activity over several days, although the increase was
clearly lower than in the 10% FBS conditions.
Mechanical loading of tendon cells
Cells were seeded two dimensionally on a Bioflex culture plate
membrane treated with collagen I (Bioflex; BF-3001C) at a density
of 1.75610
5cells/well and settled 1 day prior to cyclic strain.
Strain was applied equibiaxially to adherent cells via vacuum
deformation of the membrane downwards across a 25 mm
diameter cylindrical loading post (Fig. 2). 10% strain was applied
with a frequency of 1 Hz for a total of 120 min. Cells were
exposed to one bout of cyclic strained per day for 3days, before
being analysed. The protocol was based on an earlier study [28]. A
FlexCell unit FX-4000 (FlexCell international corporation) was
used to apply strain. See Fig. 2 for further details.
Immunocytochemistry
1.5610
4 cells were seeded per well on 8-well chamber slides (BD
Falcon 354118) overnight before being processed for vimentin,
tenomodulin, SP, and NK-1 R.
A monoclonal mouse anti-vimentin antibody, clone V9, (Dako,
Glostrup, Denmark; code: M0725), a goat polyclonal anti-
Figure 1. Tissue harvesting. Surgical harvesting of tendon tissue
from healthy donors under sterile conditions.
doi:10.1371/journal.pone.0027209.g001
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rabbit polyclonal anti-SP antibody (Serotec, Oxford, UK; code:
8450-0004), and a goat polyclonal anti-NK-1 R antibody (Santa
Cruz; code: sc-5220) were used at concentrations of 1:100 on fixed
cell cultures. Cells were fixed in 2% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4) for 5 min followed by 463 min wash in
phosphate buffered saline (PBS). After blocking with rabbit normal
serum, donkey normal serum, swine normal serum, and donkey
normal serum, for vimentin, tenomodulin, SP, and NK-1 R,
respectively, at a concentration of 1:20 for 15 min, the culture
slides were incubated with the primary antibody 60 min at 37uC.
After additional washing and blocking, the secondary antibody,
[TRITC rabbit anti-mouse (Dako; R0270), FITC donkey anti-
goat (Jackson immunoresearch; 705-095-147), TRITC swine anti-
rabbit (Dako; R0156) or FITC donkey anti-goat, for vimentin,
tenomodulin, SP, and NK-1 R, respectively] was incubated 30
min at 37uC before washing and mounting in Vectashield H-1000
mounting medium for fluorescence (Vector Laboratories, Burlin-
game, California, USA). For double-stainings the same protocol
was repeated before mounting. A Zeiss Axioskop 2 plus
microscope equipped with epifluorescence and an Olympus
DP70 digital camera was used for analysis.
Enzyme immunoassay (EIA)
1. Cell lysis. Cell pellets were suspended and incubated on ice
for 30 min in lysis buffer [100 Mm Tris-HCI buffer pH 7.0
containing 1 M NaCl, 2% Bovine Serum Albumine (BSA), 4 mM
EDTA, 0.2% Triton X-100, 0.02% sodium azide buffer]
supplemented with protease inhibitors Pepstatin A (P4265,
0.1 mg/mL), aprotinin (A1153, 5 mg/mL), antipain (A6191,
0.5 mg/mL), benzamidin (B6506, 167 mg/mL) and PMSF (P7626,
5.2 mg/mL), all from Sigma (Sigma Steinheim Germany). Lysates
were centrifuged at 13,000 g at 4uC for 15 min and the supernatant
was retained. Protein determination was done with Protein Assay
Dye Reagent Concentrate (Bio-Rad 500-0006).
2. Processing. SP concentration was analysed with a
commercially available immunoassay kit (EK-061-05 Phoenix
Pharmaceuticals, CA, USA). The assay was performed according
to the manufacturer’s instructions. Briefly, protein was added to
the blocked wells pre-coated with the secondary antibody and
thereafter incubated. Afterwards, rehydrated primary antibody
and rehydrated biotinylated peptide were added and incubated
followed by incubation with SA-HRP solution. For detection,
TMB substrate was added and the absorbance was read at
450 nm.
Western Blot
1. Cell lysis. Cell lysates were obtained after re-suspending
cell pellets in lysis buffer [150 mM Sodium chloride, 1% Triton,
0.5% Sodium deoxycholate, 0.1% Sodium Dodecyl Sulphate
(SDS), 50 mM Tris, pH 8.0 and protease inhibitor cocktail 1:200
(all from Sigma-Aldrich)] on ice for 30 min with constant
agitation. After centrifugation 5 min at 11,300 g in 4uC, to
remove cell debris, protein determination was done with Protein
Assay Dye Reagent Concentrate (Bio-Rad 500-0006) using Bovine
Albumin Serum (BSA, Sigma A9647) as a standard.
2. Process. Samples of similar total protein concentration
were boiled in 2x Lammeli sample buffer (Bio-Rad 161-0737)
supplemented with 5% beta-mercaptoethanol (Scharlau Me0095)
for 5 min at 95uC before loaded onto SDS-PAGE separating gel.
The gels were run at 160 V for 60 min then transferred to
Polyvinylidene Fluoride Transfer Membrane (PVDF; Santa Cruz;
sc-3723) for 1 h at 100 V. The membrane was blocked in TBS-T
supplemented with 5% Marvel non-fat milk powder for 60 min on
constant agitation in room temperature, and then incubated with
primary antibodies in blocking buffer overnight at 4uC. The
primary antibody for phosphorylated ERK1/2 (phospho-ERK1/
2) detects phosphorylated Thr202 and Tyr204 of ERK1/2, and
was used at a concentration of 1:2000 (Cell signal, Danvers, MA,
USA; code: 4370). The primary antibody for NK-1 R was used at
concentrations of 1:4000 (Sigma-Aldrich, Saint Louis, MO, USA;
code: s8305). This was followed by 665 min of washing in TBS-T
before incubation of HRP-conjugated secondary antibody, 1:2000
(Cell Signal; code: 7074) at room temperature for 60 min. After
665 min washes in TBS-T, membranes were treated with
chemiluminescent HRP substrate (GE Healthcare; RPN2132)
for 5 min prior to visualization on high performance
chemiluminescence film (GE Healthcare; 28-9068-38).
Equal loading was confirmed by re-blotting the membrane with
beta-actin (Cell Signal; code: 4967) after treatment with Western
blot stripping buffer (Thermo Scientific; 21059) for 25 min at
37uC with constant agitation.
RNA isolation, reverse transcription, and qPCR
Total mRNA was extracted using an RNA extraction kit
(Qiagen; 74106) following the manufacture’s protocol. Briefly, cells
were washed and placed in RLT buffer supplemented with 1%
beta-mercaptoethanol and thereafter pipetted into QIAshredders
(Qiagen; 79656) and centrifuged. One volume of 70% ethanol,
diluted in RNA free water, was added and the product was
transferred into RNeasy spin columns. After one wash in RW1
Figure 2. FlexCell system for 2D-loading of tenocytes. Schematic picture illustrating the function of the FlexCell system. Vaccum traction
applied to the membrane from the under-surface edge of the cylindrical loading post results in an equibiaxially tension on cultures as the membrane
is strained downwards. Artwork by G. Andersson.
doi:10.1371/journal.pone.0027209.g002
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was added to collect total RNA. Subsequently, RNA concentra-
tion was measured using a spectrophotometer Nanodrop ND-
1000 (Thermo Fisher Scientific).
The isolated RNA was reverse transcribed into cDNA using a
High Capacity cDNA Reverse Transcription kit (Applied
Biosystems; 4368813). A total sample volume of 14.2 ml was
diluted in a mixture consisting of 2 ml 10x RT buffer, 0.8 ml 25x
dNTP, 2 ml 10x RT random primers, and finally 1 ml 20x
multiscribe RTase to obtain a total volume of 20 ml. The
conversion of RNA to cDNA was done with the following settings;
10 min at 25uC followed by 120 min at 37uC before being paused
at 4uC on a thermal cycler (Eppendorf Mastercycler EP Gradient
S, Eppendorf, North America).
Quantitative PCR (qPCR) was performed using TaqMan fast
universal PCR master mix (Applied Biosystems; 4352042) and
probes for TAC1 (Applied Biosystems; code: Hs00243225) and
NK-1 R (TACR1; Applied Biosystems; code: Hs00185530). TAC1
is a synonym of preprotachykinin A (PPT-A), i.e. the gene from
which the SP precursors derive. For reactions, each sample was
run in technical duplicates of a 10 ml from a starting volume of
25 ml consisting of 2 ml cDNA, 12.5 ml master mix, 1.25 ml of 20x
probes and 9.25 ml RNase free water. For each amplification, a
total of 20 ng cDNA was utilized. The following conditions for
amplification were used; after 20 s of denaturation at 95uC the
amplification was carried out consisting of 3 s at 95uC for
denaturation and 30 s at 60uC for annealing/extension with the
7500 Fast Real-Time PCR systems (Applied Biosystems; version
2.0.1). The expression level of the specific genes was determined
relative to that of 18 s RNA, ribosomal RNA control reagents
(Applied Biosystems; 4308329).
Substances for experimental designs
For experimental trials, the cells were incubated in SP peptide
(Calbiochem, San Diego, USA; code: 05-23-0600) at a concen-
tration of 10
27 M, based on earlier studies [20,29]. For evaluation
of specific receptor mediated effect, an NK-1 R antagonist (Sigma;
code: s3144) was used, and found to have optimal blocking effect
at a concentration of 10
-6 M. The NK-1 R antagonist was
incubated 30 min prior to the exposure of SP in the blocking
experiments.
MTS assay-cell viability determination
The colorimetric MTS assay was performed to assess metabolic
activity in cells. This assay is composed of solutions of a
tetrazolium compound [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt;
MTS] and an electron coupling reagent, phenazine methosulfate
(PMS), which is bioreduced into formazan by living cells. The
resulting formazan precipitate was measured at 490 nm using an
enzyme-linked immunosorbent assay (ELISA) reader.
Cells were plated at a density of 5610
3 cells per well on a 96-
well plate (Corning; Costar 3300) and allowed to adhere and settle
overnight followed by serum-starvation 24 h before SP was added
for 48 hours, and then MTS was added according to instructions.
The metabolic activity is expressed as a value of absorbance in
cells and medium normalized to the absorbance of the medium.
Crystal violet
For determination of viable cell number, crystal violet staining
was performed. Cells were cultured at a density of 1.5610
5 cells
per well on a 6-well plate in triplicates. After allowing the cells to
adhere overnight they were serum starved for 24 h, then exposed
to SP and the NK-1 R blocker at concentrations stated above, and
finally analyzed after an additional 24 h. Non-adherent cells were
removed by carefully washing them twice in PBS. The remaining
adherent cells were fixed in 1% glutaraldehyde for 30 min. After
further washing in PBS, cells were stained for 30 min in 0.1%
crystal violet (Sigma; code: C3886) followed by washing in an
abundance of water. Cultures were air dried and dissolved in 30%
methanol and 10% acetic acid and placed on a shaker for 10 min
before the absorbance was read at 590 nm.
5-Bromo-29-deoxy-uridine (BrdU) cell proliferation assay
Cells were plated at a density of 1.5610
4 cells on an 8-well
chamber slides (BD Falcon; 354118) in triplicates, incubated
overnight, then serum-starved for 24 h. After serum-starvation
cells were exposed to SP and the NK-1 R blocker at
concentrations stated above.
BrdU labelling reagent was added to each well and cells were re-
incubated in a humidified atmosphere of 5% CO2 for 120 min.
Cells were then fixed with ethanol (50 mM glycine, 100 ml EtOH,
pH2.0) for 20 min at -20uC and subsequently covered with Anti-
BrdU monoclonal antibody, which binds to BrdU incorporated to
DNA, at 37uC for 30 min. This was followed by incubation with
anti-mouse-Ig-alkaline phosphatase for 30 min at 37uC before
cells were covered in freshly made substrate solution (100 mM Tris
HCI, 100 mM NaCl, 50 mM MgCl2, ph 9.5) supplemented with
4.3 mM NBT and 3.3 mM BCIP. Cells were mounted in
Vectashield hard set medium with DAPI (Vector Laboratories
H-1500). Results are presented as the percentage of proliferating
cells (ratio proliferative cells/all viable cells).
Statistics
All data were analyzed using PASW Statistics 18 (18.0.0; SPSS
Inc., Chicago, IL, USA). Statistical tests used (one-way ANOVA,
followed by Bonferroni post-hoc test, and independent samples t-
tests) are accounted for in the ‘Results’ section, when the test in
question is applied. All results were successfully repeated at least
once. Significance was predetermined at p,0.05.
Results
Immunocytochemical staining; phenotyping of cells and
expression of the SP system
The vast majority of cultured tendon cells showed a clear
elongated fibroblastic appearance under the microscope (Fig. 3),
also evident with regular light microscopy. Very occasionally, a
few cells showed a more plump appearance and sporadically some
cells exhibited extended dendritic-like processes (cf. below). The
majority of the cells were immunopositive for the tenocyte/
fibroblast markers tenomodulin (Fig. 3a) and vimentin (Fig. 3b,
Fig. 4a).
Figure 3. Phenotyping of tenocytes by immunocytochemistry.
Two cells from the primary human Achilles tendon cell cultures stained
with immunocytochemical methods (FITC in a; TRITC in b). The cell in a
shows immunoreactions for tenomodulin (green), the cell being
counterstained with DAPI to mark the nucleus (bluish), and the cell in
b is immunostained for vimentin (red).
doi:10.1371/journal.pone.0027209.g003
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were regularly observed. When counterstaining tenomodulin-/
vimentin-positive cells with SP, the cells were frequently found to
express SP-positive intracellular immunoreactions of a punctuate
(vesicular) appearance (Fig. 4). Interestingly, a few other SP-
positive cells, with pronounced dendritic-like processes, were seen
to make interactions with cells positive for the preferred SP
receptor, NK-1 R (Fig. 5).
Detection of SP and NK-1 R proteins confirmed by EIA
and Western blot
In addition to immunocytochemical findings, the presence of SP
protein in primary tendon cell cultures was confirmed with EIA.
The mean concentration of SP was 170 pg/2610
6 tendon cells.
Western blot confirmed the presence of NK-1 R in the cultured
tendon cells (Fig. 6). Two clear bands (80 kDa and 37 kDa) were
present as expected; these bands are likely to represent the full-
length glycosylated and the truncated unglycosylated forms of the
receptor respectively.
SP mRNA increases and NK-1 R mRNA decreases in
response to mechanical loading
The mean level of SP mRNA, as measured by qPCR with a
primer-probe set targeted against TAC1, was significantly higher
(.4 fold increase) in cell cultures that had been submitted to the
mechanical loading protocol compared with cell cultures that had
not (Fig. 7a; Independent samples t-test). The opposite result was
noted for the SP receptor, i.e. NK-1 R mRNA was significantly
lower in loaded cell cultures than unloaded (Fig. 7b; Independent
samples t-test).
NK-1 R expression decreases after submission of SP
The expression of the full-length glycosylated NK-1 R, as seen
with Western blot, was lower in cells incubated with SP for 4 hours
as compared to control cells (Fig. 8).
SP stimulates tendon cell metabolic activity and
proliferation, and activation of ERK1/2
Initial results of MTS-assay 48 hours after adding SP to cells in
serum free culture media, showed that SP significantly increased
the metabolic activity in the cultures, as compared to incubation
with pure media or ordinary PBS, but not as much as incubation
with cell culture media with 10% fetal calf serum or a serum-free
growth factor (Q333; PAA; U15-813) (Fig. 9; One-way ANOVA,
followed by Bonferroni post-hoc test.).
The effects of SP on the number of viable tendon cells was
confirmed with another method (crystal violet staining; Fig. 10),
and the significant increase in the number of cells seen after 24
Figure 4. Human Achilles tendon cells in culture immunopo-
sitive for SP and vimentin. (a) Cells stained with DAPI (bluish), to
mark nuclei, and immunolabeled for vimentin (red; TRITC-staining). (b)
Same cells stained with DAPI and immunolabeled for SP (green; FITC-
staining). Clear SP-reactions are seen close to the nuclei (arrows). (c)
Digitally merged image of a and b; SP appearing in yellow colour.
doi:10.1371/journal.pone.0027209.g004
Figure 5. Cells from primary human Achilles tendon cell cultures showing dendritic-like processes. The cells are double-stained for SP
(a; red; TRITC-staining) and the SP-receptor, NK-1 R (b; green; FITC-staining). The pictures (same cells shown in different filters) show that one cell
(filled arrow), positive for SP, and another cell (unfilled arrow), negative for SP but displaying positive NK-1 R reactions (filled arrowheads), are making
contact with each other via a dendritic-like process (unfilled arrowhead) from the latter cell. Digitally merged image in c.
doi:10.1371/journal.pone.0027209.g005
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NK-1 R antagonist (Fig. 10; One-way ANOVA, followed by
Bonferroni post-hoc test).
When measuring the percentage of proliferating (BrdU-postive)
tendon cells in cultures after incubation with SP, the fraction of
proliferating cells was significantly increased after both 2 and 4
hours of SP incubation as compared to controls (Fig. 11). This
effect of SP was blocked with the NK-1 R antagonist (Fig. 12;
One-way ANOVA, followed by Bonferroni post-hoc test).
Complementary Western blot analysis showed that the
exogenously administered SP stimulated phosphorylation of
ERK1/2 in the cultured cells; this activation displayed a biphasic
course, peaking after 5 and 15 minutes of exposure (Fig. 13). The
ERK1/2 activation by SP was effectively blocked when incubated
simultaneously with the NK-1 R blocker (Fig. 13).
Discussion
Primary human Achilles tendon cell culture model
This study establishes primary human Achilles tendons cells as a
valid model for studying effects of neurochemical mediators, in this
caseSP, on human tenocytes. Studies on tendon pathologyusing cell
cultures are common, although most research is performed on
animal-derived tendon cells and/or established/immortalised cell
lines. Nevertheless, other groups have successfully grown primary
human Achilles tendon cells in culture (e.g., [30,31,32]). In our
study, the overwhelming majority of cultured cells showed
characteristics of a fibroblastic phenotype, retained in passages used
for experiments (three through six), confirming that the study is
performed on cell cultures consisting almost entirely of tenocytes (i.e.
fibroblasts derived from the tendon proper). However, one should
keep in mind that tendons in vivo also consist of other cell types than
tenocytes,suchaschondrocytesandendothelialcells[33],adipocytes
[34], and nerve cells [5]. It is also known that the tendons harbour
tendon stem cells that can differentiate intoadipocytes, chondrocytes
and osteocytes [35]. A few cells of the primary cultures of the present
study actually did display rare positive reactions of such cell types
(data not shown). Regarding nerve cells, it is also observed that some
cells in the cultures of this study have dendritic-like processes, which
further indicates that nerve cells might be present.
To ensure that the majority of our cells were tenocytes, we
phenotyped the cell population with vimentin, a type III
intermediate filament seen in mesechymal derived cells such as
fibroblasts [36], and also tenomodulin, a type II transmembrane
glycoprotein which is predominantly expressed in tendon and
ligaments, and is considered to be a marker fairly specific for
tenocytes [37,38,39].
Human Achilles tendon cells produce SP and express NK-
1 R in culture
This study produces direct evidence that human tendon cells
produce SP as shown by immunocytochemistry and EIA.
Figure 6. NK-1 R in human primary Achilles tendon cells. Two
clear bands of 80 kDa and 37 kDa, respectively, are shown. b-actin is
shown as a reference.
doi:10.1371/journal.pone.0027209.g006
Figure 7. Results of loading on gene expression. qPCR analysis for SP (a) and NK-1 R (b) mRNA, respectively, in cultured human primary Achilles
tendon cells. The mean level of SP mRNA is significantly elevated after 2D-loading of the cultures, whereas the mean level of NK-1 R mRNA is
significantly lowered after the loading. Error bars represent standard error of the mean. Level of significance: * p,0.05; **p,0.01 (Independent
samples t-test).
doi:10.1371/journal.pone.0027209.g007
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[11]. The concentration of SP detected (170 pg/2610
6 tendon
cells) seems reasonable; rat thymocytes for instance produce SP in
the range of 50–175 pg/5610
6 cells [40]. It should be noted, that
in a rat tendinosis model (flexor digitorum tendons), SP-
immunoreactivity was shown in additional cell types associated
with tendons, aside from tenocytes, such as peritendon mast cells
and macrophages [41].
Furthermore, it is clear that the tendon cells still express NK-1
R in vitro. This has previously been shown in studies on human
tendon tissue sections [11,17]. This is important to establish, since
it provides a theoretical basis for specific SP effects to be exerted
on the cultured cells, as in in vivo situations. The NK-1 R detection
via Western blot clearly showed two bands (80 kDa and 37 kDa),
which likely represent the full-length glycosylated and the
truncated unglycosylated form of the receptor, respectively. It is
known that both types of the receptor have similar affinity to SP.
However, regarding phosphorylation of ERK1/2, it is previously
shown that stimulation of the full-length glycoslated form of NK-1
R more rapidly results in ERK1/2 phosphorylation [42,43]. This
most likely explains the biphasic peaking of ERK1/2 phosphor-
ylation in our result, the full-length glycosylated receptor peaking
at 5 min and the truncated unglycosylated receptor peaking at
15 min.
Figure 8. Effect of SP incubation on NK-1 R expression. Full-
length glycosylated NK-1 R expression (Western blot) in cultured human
primary tendon cells is lower in cells incubated with SP (10
27 M) for 4
hours (right) as compared to control cells (left).
doi:10.1371/journal.pone.0027209.g008
Figure 9. Metabolic activity after SP incubation. Incubating
human tendon cells with SP (10
27 M) for 48 hours significantly increases
their metabolic activity compared to incubation with pure cell culture
media or PBS. The potency of SP as a proliferative factor is about half
that of cell culture media with 10% fetal calf serum (FCS). As another
positive reference, results from incubation with a cell culture medium
with a serum-free growth factor (Q333) are shown. Results from MTS-
assay analysis. Serum-free media set as standard to 1. Error bars
represent standard deviation. **p,0.01.
doi:10.1371/journal.pone.0027209.g009
Figure 10. Cell viability after SP incubation and NK-1 R
blocking. Analysis of viable tendon cells in human primary cultures
after 24 hours of incubation with SP (10
27 M), without SP (control), and
with SP and the NK-1 R blocker (10
26 M), as measured with crystal violet
staining. The significant increase in viable cells seen after incubation
with SP is effectively blocked with the NK-1 R antagonist. Error bars
indicate standard deviation. *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0027209.g010
Figure 11. SP effect on cell proliferation at different time-
points. The mean fraction of proliferating (BrdU-positive) tendon cells
in human primary cultures after incubation with SP (10
27 M) was seen
to be significantly higher than in cultures not incubated with SP
(control) at both 2 and 4 hours of incubation. Error bars represent
standard deviation. *,0.05; **p,0.01 (Independent samples t-test).
doi:10.1371/journal.pone.0027209.g011
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appeared to form functional interactions in the cultures, SP-
positive cells making close contact with NK-1 R-positive cells.
SP production increases with mechanical loading
whereas NK-1 R expression decreases
When subjecting two-dimensionally cultured tenocytes to cyclic
load according to a protocol (10% strain, 1 Hz, 120 min every day
for 3 days), SP mRNA was significantly increased (more than four-
fold) as compared to unloaded control cells. This is in agreement
with our in vivo model of tendinosis, in which we recently
demonstrated that a repetitive loading protocol of the triceps surae
muscle, with periods of rest in between, accelerates intratendinous
SP production in the Achilles tendon tissue of rabbit [26]. In
humans, circulating levels of SP have been shown to be elevated
after exercise [44]. Regarding the loading protocol used here, in a
recent study on tenocyte differentiation in cells from a mesenchy-
mal cell line, we showed that loading of the cells in a 3D collagen
environment (bioartificial tendons) most efficiently increased
tenocyte gene expression when cyclic loading was applied, and
periods of rest inserted between loading further enhanced tenocyte
gene expression as did increasing strain levels up to 10% [28]. We
did not assess the affect of three-dimensional vs two-dimensional
culturing in the current study, but this may be worthy of further
research in the future. Nonetheless, in this case the 2D in vitro
system performed well as a way to model the effects already
observed in vivo.
Contrary to the results of SP, the present study shows that NK-1
R mRNA in tendon cells is significantly decreased (about three
times), when cells are submitted to mechanical loading. One
possible explanation for this is that the NK-1 R decrease is
secondary to the SP increase, this being the result of a negative
loop, i.e. the more SP that stimulates NK-1 R, the fewer receptors
are expressed [45]. Indeed, this theory seems to be strengthened
by additional results of the present study, showing that Western
blot analysis of NK-1 R expression is lower in the tendon cells after
4 hours of incubation in 10
27 M of SP.
It has also been shown that exposure of SP on hamster ovary
cells causes a decrease of 90% in NK-1 R responsiveness,
desensitization, along with a decrease of 50% in the amount of
membrane binding sites as the receptor internalizes following
binding to SP [46]. However, during resensitization, there is a
significant increase in receptor responsiveness without the
membrane binding sites being increased, i.e. before the receptor
is recycled [46].
We have also found a similar response (divergent mRNA levels
for SP and NK-1 R) in human (hamstring) tenocytes when co-
cultured with mast cells, i.e. SP mRNA is decreased when
tenocytes are co-cultured whereas NK-1 R mRNA is increased.
Thus it appears that coordinate regulation of SP and NK-1 R may
be a general phenomenon in human tenocytes (unpublished data).
Tenocyte proliferation and metabolic activity is increased
after exogenous SP stimulation; specific NK-1 R mediated
effects possibly via activation of mitogen-activated
protein kinases
This study shows that when primary human tenocytes in culture
are submitted to exogenous SP, this activates the phosphorylation
of the mitogen-activated protein kinases ERK1/2 already after 5
minutes. This activation showed a biphasic course, peaking at 5
and 15 minutes, which might correspond to the different forms of
the receptor [42,43]; the activation via the full-length glycosylated
receptor peaking at the earlier time point and the activation via the
truncated unglycosylated receptor peaking at the later time point.
The phosphorylation of ERK1/2 by SP is effectively blocked by
an NK-1 R inhibitor, confirming that the SP effect is specifically
mediated primarily via this receptor. It is well known that GPCRs
like NK-1 R are involved in mitogenic signals leading to
proliferation; activation via mitogen-activated protein kinases
being one such well-known pathway [19]. In colonocytes it has
been shown that SP increases cell proliferation via ERK1/2
through an epidermal growth factor receptor (EGFR) signalling
pathway [20].
After an additional 2–4 hours of incubation with SP, it is here
shown that the fraction of proliferating human tenocytes increases
Figure 12. Cell proliferation after SP incubation and NK-1 R
blocking. The mean fraction of proliferating (BrdU-positive) tendon
cells in human primary cultures after 4 hours of incubation with SP
(10
27 M), without SP (control), and with SP and the NK-1 R blocker
(10
26 M). The significant increase in the percentage of proliferating cells
seen after incubation with SP is effectively abolished with the NK-1 R
blocker. Error bars represent standard deviation. **p,0.01.
doi:10.1371/journal.pone.0027209.g012
Figure 13. SP effect on activation of mitogen-activated protein
kinases. Phosphorylated ERK1/2 in cultured human Achilles tendon
cells at different time points after incubation with SP (10
27 M). The
results clearly show that SP activates the phosphorylation of ERK1/2
over time in a biphasic course that peaks at 5 and 15 minutes of
exposure. The activation by SP is effectively blocked when incubated
simultaneously with the NK-1 R blocker (10
26 M; result at 5 min to the
right). Beta(b)-actin is shown as a reference.
doi:10.1371/journal.pone.0027209.g013
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SP effect is also blocked by the NK-1 R inhibitor. One to two days
(24–48 h) after SP exposure the number of viable cells and the
metabolic activity were significantly increased, strengthening that
SP indeed stimulates proliferation of human tenocytes; this being
specifically mediated via NK-1 R and possibly through the
activation of ERK1/2.
These results are again in accordance with the findings of our
studies in the in vivo tendinosis model. The increase in the load-
induced endogenous SP production seen in the rabbit Achilles
tendon was found to precede the tendinosis tissue changes,
including tenocyte hypercellularity [26], and exogenously admin-
istrated SP accelerated the tendon cell proliferation [27].
Earlier studies on the effects of SP on human fibroblasts (skin
derived) in culture, have also shown that SP, under certain
conditions can exert proliferative effects on these cells [47,48], and
paratendinous injections of SP also enhances cell proliferation in
rat Achilles tendons during wound healing [13,14]. Most
interestingly, exogenously administered SP seems to have a
booster effect on endogenous SP for rat fibroblast proliferation
via autocrine/paracrine stimulation in an Achilles tendon rupture
model [49].
Conclusions
In summary, this study confirms that human Achilles tendon
tenocytes are capable of producing SP and that they express NK-1
R. The results furthermore suggest that when tenocytes are
submitted to mechanical loading, the SP production increases,
providing a possible explanation of elevated peripheral SP levels in
strain-induced conditions, such as tendinosis [26]. Moreover, it is
here experimentally shown that SP triggers proliferation of human
Achilles tendon tenocytes through a NK-1 R specific pathway,
giving further evidence of a possible involvement of SP in the
pathology of tendinosis, specifically in the excessive cell prolifer-
ation that occurs [1]. The activation of MAPKs by SP is in
accordance with established knowledge on GPCR mediated
proliferative effects; further validating the importance of the
NK-1 R.
In conclusion, the present study indicates that SP, produced by
tenocytes in response to mechanical strain, regulates cell
proliferation through an autocrine loop involving the NK-1 R.
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